AU7165998A - Neurotrophic factor receptors - Google Patents

Neurotrophic factor receptors

Info

Publication number: AU7165998A
Authority: AU; Australia
Prior art keywords: neurotrophic factor; factor receptors; receptors; neurotrophic; factor
Prior art date: 1997-05-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU71659/98A

Inventor

Gary M. Fox

Shuqian Jing

Duanzhi Wen

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Amgen Inc

Original Assignee

Amgen Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-05-30

Filing date

1998-04-27

Publication date

1998-12-30

1997-05-30 Priority claimed from US08/866,354 external-priority patent/US7138251B1/en

1998-04-27 Application filed by Amgen Inc filed Critical Amgen Inc

1998-12-30 Publication of AU7165998A publication Critical patent/AU7165998A/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Psychiatry (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Cell Biology (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Hospice & Palliative Care (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Investigating Or Analysing Biological Materials (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicinal Preparation (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AU71659/98A 1997-05-30 1998-04-27 Neurotrophic factor receptors Abandoned AU7165998A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US08866354		1997-05-30
US08/866,354 US7138251B1 (en)	1996-04-22	1997-05-30	Polynucleotides encoding a neurotrophic factor receptor
PCT/US1998/008486 WO1998054213A2 (en)	1997-05-30	1998-04-27	Neurotrophic factor receptors

Publications (1)

Publication Number	Publication Date
AU7165998A true AU7165998A (en)	1998-12-30

Family

ID=25347430

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU71659/98A Abandoned AU7165998A (en)	1997-05-30	1998-04-27	Neurotrophic factor receptors

Country Status (6)

Country	Link
EP (1)	EP0983354A2 (en)
JP (1)	JP2002505576A (en)
AU (1)	AU7165998A (en)
CA (1)	CA2291608C (en)
WO (1)	WO1998054213A2 (en)
ZA (1)	ZA984404B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6696259B1 (en)	1995-11-13	2004-02-24	Licentia Ltd.	Assays using glial cell line-derived neurotrophic factor receptors
US6677135B1 (en)	1996-05-08	2004-01-13	Biogen, Inc.	Ret ligand (RetL) for stimulating neutral and renal growth
WO1998052591A1 (en) *	1997-05-22	1998-11-26	Cephalon Inc.	Glial cell line-derived neurotrophic factor receptors
WO1999049039A2 (en)	1998-03-23	1999-09-30	Genentech, Inc.	GFRα3 AND ITS USES
US7026138B1 (en)	1998-03-23	2006-04-11	Genentech, Inc.	Polynucleotides encoding GFRα3
DE19816186A1 (en) *	1998-04-14	1999-10-21	Univ Muenchen L Maximilians	GDNF-encoding DNA, parts thereof and GDNF variants
WO2015012944A1 (en) *	2013-07-22	2015-01-29	Armagen Technologies, Inc	Methods and compositions for increasing enzyme activity in the cns
NZ754163A (en)	2016-11-10	2026-01-30	Keros Therapeutics Inc	Gdnf fusion polypeptides and methods of use thereof
CN114555814A (en) *	2019-09-13	2022-05-27	罗特格斯新泽西州立大学	AAV-compatible laminin-linker polyproteins

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4006054A1 (en) *	1990-02-26	1991-08-29	Boehringer Mannheim Gmbh	METHOD FOR THE IMMUNOLOGICAL DETERMINATION OF LIGANDS
ES2178654T3 (en) *	1993-08-12	2003-01-01	Neurotech Sa	IMMONO-ISOLATED BIOCOMPATIBLE CAPSULES CONTAINING GENETICALLY ALTERED CELLS FOR THE SUPPLY OF BIOLOGICALLY ACTIVE MOLECULES.
US6455277B1 (en) *	1996-04-22	2002-09-24	Amgen Inc.	Polynucleotides encoding human glial cell line-derived neurotrophic factor receptor polypeptides
CA2253871C (en) *	1996-05-08	2005-04-26	Biogen, Inc.	Ret ligand (retl) for stimulating neural and renal growth
EP0846764A3 (en) *	1996-11-27	1998-09-30	Smithkline Beecham Plc	Glial cell line-derived neurotrophic factor alpha receptor family
DE69832797T2 (en) *	1997-02-18	2006-08-17	Genentech, Inc., South San Francisco	Neurturin RECEPTOR

1998
- 1998-04-27 WO PCT/US1998/008486 patent/WO1998054213A2/en not_active Ceased
- 1998-04-27 JP JP50067499A patent/JP2002505576A/en not_active Ceased
- 1998-04-27 CA CA002291608A patent/CA2291608C/en not_active Expired - Lifetime
- 1998-04-27 AU AU71659/98A patent/AU7165998A/en not_active Abandoned
- 1998-04-27 EP EP98918805A patent/EP0983354A2/en not_active Withdrawn
- 1998-05-25 ZA ZA984404A patent/ZA984404B/en unknown

Also Published As

Publication number	Publication date
WO1998054213A3 (en)	1999-01-07
CA2291608A1 (en)	1998-12-03
JP2002505576A (en)	2002-02-19
CA2291608C (en)	2004-04-13
EP0983354A2 (en)	2000-03-08
WO1998054213A2 (en)	1998-12-03
ZA984404B (en)	1998-12-01

Publication	Publication Date	Title
AU8778098A (en)	1999-03-01	Tubular connection
IL154542A0 (en)	2003-09-17	The neurotrophic factor nnt-1
AU7966098A (en)	1998-12-30	Hm74a receptor
AU2354600A (en)	2000-06-26	Grnf4 a neurotrophic factor
AU7132898A (en)	1998-11-13	Edg-1-like receptor
AU9066598A (en)	1999-03-01	Substituted 4-benzoyl-pyrazoles
AU8391498A (en)	1999-02-08	Semaphorin receptors
AU1535699A (en)	1999-06-15	Novel receptors opg-2
EP0903415A3 (en)	2003-01-29	Structure expansée
AU1334799A (en)	1999-05-10	Novel cytokine receptors
AU7165998A (en)	1998-12-30	Neurotrophic factor receptors
AU8072498A (en)	1999-01-04	Heregulin-like factor
AUPO938697A0 (en)	1997-10-16	Novel receptor
AU6673898A (en)	1998-09-22	Factor x variant
AU7067598A (en)	1998-11-24	Support structure
AU7583898A (en)	1998-12-11	Gdnf receptors
HUP0001969A3 (en)	2002-01-28	The neurotrophic factor nnt-1
AU6090898A (en)	1998-07-31	Substituted 4-benzoyl-pyrazoles
AU1873499A (en)	1999-06-07	Semi-submersible structure
AU3543599A (en)	1999-10-18	Receptors
AU6826498A (en)	1998-10-12	Endotholin receptor antagonists
AU6916898A (en)	1998-12-30	Stadium
AU7226598A (en)	1998-12-08	Stay
AU7530198A (en)	1998-11-27	Substituted 4-benzoyl-pyrazoles
AU8131798A (en)	1999-02-08	Lamp

Legal Events

Date	Code	Title	Description
2000-02-10	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase